Strand Life Sciences Closes Series B Financing with Burrill & Company

Strand Life Sciences, a Bangalore, India-based bioinformatics company developing healthcare applications, completed a Series B round of financing with Burrill & Company.

The financing -whose amount was not disclosed – included both a primary investment and a secondary buy-out of the lead Series A investors.

The company intends to use the capital to continue to grow into precision diagnostics in healthcare and expand its reach into global markets.

Led by Dr. Vijay Chandru , Founder, Chairman and CEO, Strand develops informatics products and services for research biologists, chemists, and toxicologists that combine advanced visualization, predictive systems modeling, data integration and scientific content management.
Clients include research laboratories worldwide, and pharmaceutical and biotechnology companies.



Join the discussion